Table 4. Network meta-analysis results for mortality, post MI, TIE, A-fib, and inotrope.

Network meta-analysis (mortality), no inconsistency (p** = 0.39)
OR (95%CI)	Placebo	DILT	NTG
Placebo (vs.)	-	1.42 (0.39, 5.22)	1.37 (0.40, 4.64)
DILT (vs.)	0.70 (0.19, 2.57)	-	0.96 (0.35, 2.64)
NTG (vs.)	0.73 (0.22, 2.47)	1.04 (0.38, 2.81)	-
Network meta-analysis (post-MI), no inconsistency (p** = 0.99)
OR (95%CI)	Placebo	DILT	NTG
Placebo (vs.)	-	4.51 (1.34, 15.25)	2.26 (0.85, 5.99)
DILT (vs.)	0.22 (0.07, 0.75)	-	0.50 (0.20, 1.24)
NTG (vs.)	0.44 (0.17, 1.18)	2.00 (0.80, 4.96)	-
Network meta-analysis (TIE), no inconsistency (p** = 0.93)
OR (95%CI)	Placebo	DILT	NTG
Placebo (vs.)	-	2.21 (0.94, 5.21) *	1.43 (0.73, 2.77)
DILT (vs.)	0.45 (0.19, 1.07) *	-	0.64 (0.38, 1.11)
NTG (vs.)	0.70 (0.36, 1.36)	1.55 (0.90, 2.66)	-
Network meta-analysis (A-fib), no inconsistency (p** = 0.46)
OR (95%CI)	Placebo	DILT	NTG
Placebo (vs.)	-	2.86 (0.65, 12.61)	1.10 (0.20, 5.97) *
DILT (vs.)	0.35 (0.08, 1.55)	-	0.39 (0.18, 0.85)
NTG (vs.)	0.91 (0.17, 4.88) *	2.58 (1.18, 5.67)	-
Network meta-analysis (Inotrope), no inconsistency (p** = 0.14)
OR (95%CI)	Placebo	DILT	NTG
Placebo (vs.)	-	0.51 (0.16, 1.61)	0.28 (0.06, 1.21) *
DILT (vs.)	1.95 (0.62, 6.11)	-	0.55 (0.21, 1.41)
NTG (vs.)	3.57 (0.82, 15.51) *	1.83 (0.71, 4.72)	-

vs.: row versus column. OR less than 1 favor the treatment specified in the row; OR greater than 1 favor the treatment specified in the column;

*: indirect comparison;

**: p-value from global test for inconsistency.